28 | | * [raw-attachment:2020-11-16-LhARA-mission.pdf Mission statement]: S. Green, A. Giacca, F.Jamieson, K.Long |
29 | | * [raw-attachment:2020-11-16:LhARA-timeline.pdf Timeline: today to clinical system]: K.Long, T.Kolkalova-Wheldon \\ |
30 | | * PPI Strategy: H.Hall, G.Jones, \\ |
31 | | * Industrial strategy: F.Jamieson, S.Towe \\ |
32 | | * Stakeholder plan: P. Price, S.Green, K. Long |
| 28 | * [raw-attachment:2020-11-16-LhARA-mission.pdf Mission statement]: **S. Green, A. Giacca, F.Jamieson, K.Long** |
| 29 | * [raw-attachment:2020-11-16:LhARA-timeline.pdf Timeline: today to clinical system]: **K.Long, T.Kolkalova-Wheldon** |
| 30 | * PPI Strategy: **H.Hall, G.Jones** |
| 31 | * Industrial strategy: **F.Jamieson, S.Towe** |
| 32 | * Stakeholder plan: **P.Price, S.Green, K. Long** |